PDS Biotechnology Statistics
NASDAQ: PDSBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.07+0.02 (+1.91%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.03 -3.29%
PDS Biotechnology by the numbers
PDS Biotechnology has a market capitalization of $77.2 million based on 72.47M shares outstanding. With trailing EPS of $-0.65, PDS Biotechnology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 99.6% above its 50-day average and 33.4% above its 200-day average.
Average daily trading volume is 23.18M shares, or about $24.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PDSB valuation vs. peer median
| Metric | PDSB | Peer median | Difference |
|---|---|---|---|
| Market cap | $77.19M | $76.25M | +1% |
| Avg. volume | 23.18M | 344.68K | +6625% |
Peer median across 8 companies: LFVN, RFL, INCR, NTHI, ONCY, HRTX, GANX, MAIA.
Valuation
- Market cap
- $77.19M
- EPS (TTM)
- $-0.65
- Shares outstanding
- 72.47M
Price and trading
- Previous close
- 1.05
- Open
- 1.05
- Day range
- 1.00 – 1.10
- 52-week range
- 0.195 – 1.55
- 52-week change
- +10.48%
- 50-day moving average
- 0.5335
- 200-day moving average
- 0.7983
- Beta
- —
- Volume
- 5.46M
- Average volume
- 23.18M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 77.19M
- Forward Pe
- -3.09
- Eps
- -0.65
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.55
- Week52 Low
- 0.20
- Avg Volume
- 23.18M
- Shares Outstanding
- 72.47M
- Ma50
- 0.53
- Ma200
- 0.80
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -31.29%
- Pct From52w Low
- 446.15%